As of November 10, 2026, ENvue Medical, Inc. has Schedule 13D or 13G filings on record, none whose latest reports a stake of 5% or more. 5 filings are on record since February 6, 2026 (Schedule 13D/A, June 22, 2026).
Sell to companies like ENvue Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Glibert Christian Michael · Percent: 0% · Shares: 0 · SCHEDULE 13D/A
- · Holder: Glibert Christian Michael · Percent: 6.5% · SCHEDULE 13D/A
- · Holder: Bank Of America Corp · Percent: 0% · SCHEDULE 13G/A
- · Holder: Glibert Christian Michael · Percent: 22% · SCHEDULE 13D
- · Holder: Bank Of America Corp · Percent: 21.5% · SCHEDULE 13G
ENvue Medical, Inc. has 5 Schedule 13D or 13G filings on record since 2026-02-06. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Bank Of America Corp | 0% | 14 | SCHEDULE 13G/A, 2026-03-06 | 2026-02-27 |
| 0% | 0 | SCHEDULE 13D/A, 2026-06-22 | 2026-06-22 |
Holding shares or following this stake? See who's behind ENvue Medical, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on ENvue Medical, Inc. and the records around it.
ENvue Medical, Inc. elsewhere on the record
- Leadership changes Jul 2026
- Who owns it
Companies that share a holder
- BANK OF AMERICA CORP /DE/ also filed stake reports on 74 other companies: BlackRock 2037 Municipal Target Term Trust (Nov 2026), TRIMAS CORP (Nov 2026), PIMCO CALIFORNIA MUNICIPAL INCOME FUND (Nov 2026)
Watch ENvue Medical, Inc.
Get an email when ENvue Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on ENvue Medical, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ENvue Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ENvue Medical, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Glibert Christian Michael | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-06-22 |
The latest filing identifies ENvue Medical, Inc. by CUSIP 29416M103 and gives its principal executive office as 969 PRUITT AVE, TYLER, TX 77569 (SCHEDULE 13D/A, 2026-06-22).
Purpose of Transaction (Item 4)
Glibert Christian Michael
Item 4 is hereby amended and supplemented by adding the following: This Amendment No. 2 is being filed to report that the Reporting Person has fully liquidated his investment position in the Issuer. On June 22, 2026, the Reporting Person disposed of all remaining shares of Common Stock of the Issuer held by him. Except as a result of the transactions described in Item 5, the Reporting Person has no current plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D.Item 4 of the SCHEDULE 13D/A filed 2026-06-22
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-02-06 | Bank Of America Corp | 21.5% | SCHEDULE 13G |
| 2026-02-11 | Glibert Christian Michael | 22% | SCHEDULE 13D |
| 2026-03-06 | Bank Of America Corp | 0% | SCHEDULE 13G/A |
| 2026-04-17 | Glibert Christian Michael | 6.5% | SCHEDULE 13D/A |
| 2026-06-22 | Glibert Christian Michael | 0% | SCHEDULE 13D/A |
Also on the record for ENvue Medical, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 14, 2026 | Leadership change: Zvi Joseph appointed, and 2 more | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for ENvue Medical, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.